We have always measured human progress by our advances in health. The vaccine that empties the children's ward. The test that catches the disease before it speaks. The ramp, the reader, the cochlear implant that widen the world for those it once shut out. For most of human history this was the whole of the ambition: keep the child alive, ease the suffering, return the sick to the ordinary business of living. Progress meant closing the gap between the frail body and the healthy one.
That ambition has quietly been surpassed. We have moved past treating disease, past preventing it, to enlarging what a healthy body can already do. A weekly injection now reshapes appetite and metabolism for people who were never ill. Prospective parents rank embryos not only for the diseases they might carry, but for the height and the intelligence they might pass on. A band on the wrist turns sleep, glucose, and heart rhythm into a dashboard, and invites us to manage the body the way we manage a portfolio. The wellness economy that sells this promise reached $6.8 trillion in 2024, and is on course for nearly $10 trillion by the end of the decade.
So the question is not whether medicine should advance, but how far, how fast, and toward what? Three perspectives frame the debate:
The first welcomes all of it, without apology. If a technology makes a life longer, healthier, or freer, then to refuse it is the superstition, and not the science. Every advance we now call routine was once called unnatural: anesthesia, the transplant, the child conceived in a petri dish. The objector always arrives late, and always in the same costume. On this view the only real failure of ethics is to leave a working tool on the shelf while people age, suffer, and die within reach of it. A parent who could spare a child a disease and chose not to would answer for that choice. Why should the parent who could add a gift be judged any differently?
The second answer is that we are altering something we do not understand, and cannot easily take back. This is where the regulators have planted their flags. The US Food and Drug Administration has spent the past year forcing cheap, compounded copies of the popular weight-loss drugs off the market, warning that unapproved peptides carry risks no one has measured. The World Health Organization, after a scientist edited the genes of twins born in 2018, built a global framework to govern human genome editing and urged the world not to attempt heritable changes it cannot yet judge safe. Europe goes further, banning by treaty any edit that would pass to the next generation, and outlawing the cloning of a human being outright. Even where the science is welcomed, it is fenced: the WHO's first global guideline on the weight-loss drugs, issued in December 2025, endorsed them only conditionally. The shared worry is simple. A choice made in one body may not stay in one body, and a long-term risk is, by definition, one we have not yet lived long enough to see.
The third answer grants that the technology may be safe, may be permitted, and still counts a loss. Limits are not only obstacles. They are the source of much that we prize. Aging binds the generations and gives the years their weight. A body accepted rather than optimized is the ground of a certain humility, and of a certain solidarity with everyone who shares the same fate. Engineer the struggle out of a life and we may find we have engineered out the meaning with it. The examined life was never meant to be the frictionless one.
None of this stays private for long. Enhancement is priced, and price sorts people. A world in which the wealthy screen, edit, and extend while everyone else makes do is not a healthier world. It is a more divided one, with the oldest inequality of all, the inequality of the body, now written into biology and sold by subscription.
So where do you stand? Where is the line between healing a body and improving it, and whose hand should hold the pen that draws it? Which of these tools would you accept for yourself, and which for your child? And what, if anything, would change your mind?
